| Item Type | Name |
|
Academic Article
|
Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats.
|
|
Academic Article
|
Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases.
|
|
Academic Article
|
Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats.
|
|
Academic Article
|
Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats.
|
|
Academic Article
|
Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats.
|
|
Academic Article
|
Atrial natriuretic peptide gene delivery reduces stroke-induced mortality rate in Dahl salt-sensitive rats.
|
|
Academic Article
|
Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats.
|
|
Academic Article
|
Human kallikrein gene delivery protects against gentamycin-induced nephrotoxicity in rats.
|
|
Academic Article
|
Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats.
|
|
Academic Article
|
Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima formation in the rat artery after balloon angioplasty.
|
|
Academic Article
|
Human tissue kallikrein attenuates hypertension and secretes into circulation and urine after intramuscular gene delivery in hypertensive rats.
|
|
Academic Article
|
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
|
|
Academic Article
|
Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats.
|
|
Academic Article
|
Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats.
|
|
Academic Article
|
Adenovirus-mediated gene transfer for cardiovascular and renal diseases.
|
|
Academic Article
|
Atrial natriuretic peptide gene delivery attenuates gentamycin-induced nephrotoxicity in rats.
|
|
Academic Article
|
Experimental therapy with tissue kallikrein against cerebral ischemia.
|
|
Academic Article
|
Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats.
|
|
Academic Article
|
Gene therapy for hypertension: a review of potential targets.
|
|
Academic Article
|
Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction.
|
|
Academic Article
|
Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury.
|
|
Academic Article
|
Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin.
|
|
Academic Article
|
Gene therapy with human tissue kallikrein reduces hypertension and hyperinsulinemia in fructose-induced hypertensive rats.
|
|
Academic Article
|
Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats.
|
|
Academic Article
|
Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats.
|
|
Academic Article
|
Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats.
|
|
Academic Article
|
Kallikrein gene therapy: a new strategy for hypertensive diseases.
|
|
Academic Article
|
Kallikrein-kinin in stroke, cardiovascular and renal disease.
|
|
Academic Article
|
Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
|
|
Academic Article
|
Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation.
|
|
Academic Article
|
Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
|
|
Academic Article
|
Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery.
|
|
Academic Article
|
Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation.
|
|
Academic Article
|
Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5'-monophosphate-activated protein kinase signaling pathways.
|
|
Academic Article
|
Upregulation of kallistatin expression in rheumatoid joints.
|
|
Academic Article
|
Adenovirus-mediated kallistatin gene transfer ameliorates disease progression in a rat model of osteoarthritis induced by anterior cruciate ligament transection.
|
|
Academic Article
|
Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis.
|
|
Academic Article
|
Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats.
|
|
Academic Article
|
Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein.
|
|
Academic Article
|
Kallikrein gene therapy in newborn and adult hypertensive rats.
|
|
Academic Article
|
Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery.
|
|
Concept
|
Genetic Therapy
|